If you or a loved one has been told you need a bone marrow transplant (also called a hematopoietic stem cell transplant), one of the most consequential decisions you’ll make is choosing where to have it done. Not all bone marrow transplant centers are equal — transplant volume, survival outcomes, and accreditation status vary dramatically, and these differences directly affect your chances of a good outcome.
There are roughly 200 bone marrow transplant centers in the United States, performing over 23,000 transplants per year according to the Center for International Blood and Marrow Transplant Research (CIBMTR). Some are massive academic programs doing 500+ transplants annually; others perform fewer than 50. Research consistently shows that higher-volume centers tend to have better survival rates and fewer complications — so this isn’t a decision to make based on geography alone.
What Exactly Is a Bone Marrow Transplant Center?
A bone marrow transplant center is a specialized medical facility — usually within a larger hospital or cancer center — that’s built around performing stem cell transplants and managing the intensive care these patients need before, during, and after the procedure. Think of it as an entire ecosystem: transplant hematologists, infectious disease specialists, transplant coordinators, pharmacists trained in immunosuppression, social workers, and specialized nurses all working together.
These centers handle two main transplant types:
- Autologous transplants — You receive your own stem cells back after high-dose chemotherapy. Common for multiple myeloma and certain lymphomas.
- Allogeneic transplants — You receive stem cells from a matched donor (sibling, unrelated donor, or cord blood). Used for leukemias, myelodysplastic syndromes, aplastic anemia, sickle cell disease, and thalassemia. These are significantly more complex and carry higher risk.
Allogeneic transplants are where center expertise matters most. Complications like graft-versus-host disease (GVHD), which affects 30–70% of allogeneic transplant recipients, require seasoned clinical teams who manage these cases daily — not occasionally.
How to Compare Bone Marrow Transplant Centers
Here are the key factors transplant physicians actually consider important when evaluating centers:
| Factor | What to Look For | Why It Matters |
|---|---|---|
| FACT Accreditation | Active accreditation from the Foundation for the Accreditation of Cellular Therapy | FACT-accredited centers meet rigorous quality and safety standards; many insurers require it |
| Annual Transplant Volume | At least 50 transplants/year; ideally 100+ for allogeneic | Studies show centers performing >40 allogeneic transplants/year have significantly lower mortality |
| 1-Year Survival Rates | Compare center-specific outcomes via CIBMTR’s Transplant Center Search Tool | Survival data is risk-adjusted, making center-to-center comparison meaningful |
| Disease-Specific Expertise | Ask how many patients with your exact diagnosis they transplant annually | A center may do 200 transplants/year but only 5 for your condition |
| Donor Access | Affiliation with NMDP (Be The Match); ability to perform haploidentical and cord blood transplants | Patients without a fully matched donor need centers experienced in alternative donor strategies |
| Clinical Trials | Active enrollment in transplant-related trials | Access to newer conditioning regimens, GVHD prevention strategies, and post-transplant therapies |
The CIBMTR Transplant Center Search Tool
This is the single most useful resource for patients comparing centers. Available at cibmtr.org, it lets you look up any U.S. transplant center and see how their 1-year survival rates compare to predicted outcomes. Centers are categorized as performing “as expected,” “better than expected,” or “worse than expected” based on risk-adjusted models.
A word of caution: smaller centers may not have enough transplant volume to generate statistically meaningful survival data. If a center shows “not enough data,” that itself is worth noting — it may indicate low volume.
Conditions That Lead to Transplant Referral
Your oncologist or hematologist will refer you to a transplant center when your disease is unlikely to be cured — or adequately controlled — with chemotherapy or other treatments alone. Common indications include:
- Acute myeloid leukemia (AML) — especially intermediate or high-risk subtypes after achieving first remission
- Acute lymphoblastic leukemia (ALL) — particularly in adults or after relapse
- Myelodysplastic syndromes (MDS) — the only curative option for higher-risk MDS
- Multiple myeloma — autologous transplant remains standard of care for eligible patients
- Severe aplastic anemia — especially in younger patients with a matched sibling donor
- Sickle cell disease and thalassemia major — increasingly curable with allogeneic transplant
- Relapsed or refractory lymphomas — when chemotherapy-sensitive disease is present
What to Expect During the Evaluation
Once referred, you’ll undergo a comprehensive pre-transplant workup that typically takes 1–2 weeks and includes:
- Complete blood counts and comprehensive metabolic panel
- Bone marrow biopsy to confirm disease status
- Pulmonary function tests and cardiac evaluation (echocardiogram or MUGA scan)
- HLA typing — critical for finding a matched donor in allogeneic transplant
- Cytogenetic and molecular testing to refine risk stratification
- Psychosocial assessment and caregiver planning
The transplant team uses all of this to determine whether you’re fit enough to tolerate the procedure. Transplant-related mortality is real — roughly 10–20% for allogeneic transplants depending on age, disease, and donor type — so this evaluation isn’t just a formality.
When to Get a Second Opinion at Another Center
Seek a second opinion at a high-volume transplant center if:
- You’ve been told transplant isn’t an option, but you’re under 75 with reasonable organ function
- Your local center performs fewer than 20 allogeneic transplants per year
- You have a rare disease or lack a fully matched donor
- You want access to clinical trials not available locally
- Your center’s CIBMTR outcomes are rated “worse than expected”
Many major transplant centers offer virtual consultations for second opinions, so travel isn’t always necessary for the initial evaluation.
Frequently Asked Questions
Does insurance cover treatment at any bone marrow transplant center?
Most insurers maintain a network of approved transplant centers, and many require FACT accreditation. Some plans designate “Centers of Excellence” and offer better coverage for those facilities. Always verify coverage before committing — out-of-network transplant costs can exceed $500,000.
How far in advance should I contact a transplant center?
Ideally, get the referral process started as soon as transplant is mentioned as a possibility. For acute leukemias, timing is critical — donor searches through the NMDP take a median of 2–3 months, and you don’t want to lose your remission window waiting for logistics.
Are the top bone marrow transplant centers only at big universities?
Most high-volume programs are at academic medical centers, but some large community cancer centers have excellent transplant programs. What matters more than the name on the building is volume, outcomes data, and accreditation. Check the numbers.
Can I get a transplant if I’m over 65?
Yes. Reduced-intensity (non-myeloablative) conditioning regimens have expanded transplant eligibility to patients in their 70s at experienced centers. The median age for allogeneic transplant has risen steadily — many centers now routinely transplant patients aged 65–75 with acceptable outcomes. Fitness matters more than the number on your driver’s license.
What’s the difference between a transplant center and a CAR-T center?
Many bone marrow transplant centers also administer CAR-T cell therapy, but they’re distinct treatments. CAR-T uses your own genetically modified immune cells and doesn’t require a donor. Some patients receive CAR-T as a bridge to transplant, or as an alternative. Ask whether your center offers both so all options stay on the table.
